ECP 2023 Final Programme

E-Posters 156 E-PS-15 046 Development and validation of assays for testing EGFR amplification in tissues, based on gene copies, RNA and protein expres- sion Shlomo Tsuriel, Israel V. Hannes, D. Hershkovitz 047 Implementation of the 2021 WHO Classification of Tumours of the Central Nervous System and molecular assessment of diffuse gliomas in a Belgian cohort Léon van Kempen, Belgium M. Ahmed, A. Sieben, B. Verbraeken, T. Menovsky, M. Rasschaert, P. Meijnders, P. Cras, M. Lammens 049 Mitochondrial genome variants associated with pathogenesis of colorectal cancer Olesya Vasyukova, Russia N. Shakhpazyan, N. Sadykhov, V. Pechnikova, L. Mikhaleva 050 Implementation of a Next Generation Sequencing (NGS) service for cfTNA analysis to facilitate driver mutation reporting in blood Reiltin Werner, Ireland R. Crosbie, M. Dorney, J. McCarthy, C. Hand, L. Burke 051 Spectrum of mutations in homologous recombination repair genes in metastatic hormone-sensitive prostate cancer Viktoryia Zakharava, Belarus D. Balshakova, M. Smal, R. Goncharova, A. Muradkhanau, Y. Poddubny, A. Rolevich, S. Krasny E-PS-16 E-Posters Nephropathology 001 Membranous nephropathy associated with monoclonal gammopathies: case series María Luisa Abascal Camacho, Spain C. Vieru, Y. Gómez Navarro, Ú. Verdalles Guzman, T. Bada Bosch, J. De la flor, F. Arias, M. Goicoechea Diezhandino., F. Díaz Crespo 002 Cellular variant of focal glomerulosclerosis: a single center experience María Luisa Abascal Camacho, Spain Y. Gómez Navarro, C. Vieru, M. Mora Mora, Ú. Verdalles Guzman, F. Arias, F. Díaz Crespo 003 Cristal storing light chain histiocytosis: case report María Luisa Abascal Camacho, Spain T. Bada Bosch, M. Fernandez Nieto, F. Arias, Y. Gómez Navarro, F. Menarguez Palanca 004 Anti-oxidant and anti-inflammatory effects of montelukast in preventing Iohexol-in- duced contrast-induced nephropathy in rats Elif Baris, Turkey O. Simsek, C. Ural, C. Incir, S. Aydemir, M. Gumustekin, Z. Cavdar, O. Yilmaz, S. Ozbal, M. Arici 005 Predictive value of activity and chronicity indices in lupus nephritis Irina-Draga Caruntu, Romania T. Azoicai, E. Avadanei, M. Onofriescu, A. Covic, S. Giușcă 006 Congenital nephrotic syndrome: a case series Arzu Demir, Turkey K. Erdogan, G. Gonlusen, B. Atmış, A. Karabay Bayazıt 007 Clinicopathological significance of monotypic light-chain deposition in IgA nephropathy Claudia Andrea Gomez Gonzalez, Turkey B. Sarsik Kumbaraci, B. Yaman, D. Demir, Z. Akcali, G. Asci, S. Sen 008 Significance of C4d and Jones stain in renal amyloidosis Claudia Andrea Gomez Gonzalez, Turkey A. Celtik, M. Yetisken, B. Sarsik Kumbaraci, H. Toz, S. Sen 009 Clinicopathological evaluation of 124 biopsy-proven lupus nephritis Evin Kussever, Turkey G. Gonlusen, K. Erdogan, B. Atmış, B. Kaya, A. Karabay Bayazıt, S. Paydas E-PS-16